The company says the system can benefit pharmaceutical and biotech firms seeking rapid feedback on drug candidates or genome editing.
A man with neurofibromas who didn't know he's been clinically diagnosed with NF1, learns he harbors a deeply intronic, likely ...
Elegen, a global leader in next-generation DNA manufacturing, and Nutcracker Therapeutics, a global leader in next-generation RNA design and manufacturing, today announced the launch of a pilot ...
Factors impacting treatment with abemaciclib + endocrine therapy in high risk early-stage HR+/HER2- breast cancer patients. Integration of next-generation RNA sequencing-based MammaPrint and BluePrint ...
Integration of next-generation RNA sequencing-based MammaPrint and BluePrint analysis in clinical decision making: Performance evaluation in the first 1095 cases. This is an ASCO Meeting Abstract from ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results